Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de l'Offre à environ 172,5 millions de dollars ...

Following the exercise in full of the Underwriters' Option, the total number of ADSs issued in the Offering will amount to 44,805,193, resulting in gross proceeds for the Company of approximately $172 ...

Ascend Vitality is a U.S.-based telehealth provider offering physician-directed access to peptide therapy, metabolic support, and regenerative wellness treatments. The company partners with ...

Smart sync: Data is securely transferred and displayed in Clue, alongside self-tracked symptoms and cycle information. Contextual insights: By combining wearable data with Clue tracking, members can ...

Tokyo, Japan and Cambridge and London, UK, 17 November 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces the release of two video interviews with its major shareholders, ...

Agomab Therapeutics NV (‘Agomab’) today announced positive data from 103 participants completing 12 weeks of treatment in the STENOVA 1 Phase 2a clinical trial for ontunisertib (AGMB-129), an ...

TME PHARMA ANNONCE AVOIR REÇU DES ACCORDS DE PRINCIPE POUR PROLONGER CERTAINS ACCORDS D'OBLIGATIONS Berlin, Allemagne, le 17 novembre 2025, 8h00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), ...

The share capital increase pertaining to the issuance of the in total 4,045,413 new shares in Tranche 1 and the Retail Offering has now been registered with the Norwegian Register of Business ...

The Board of Directors and CEO Monica Manotas thank Tania Micki for her strong commitment and significant contributions to Tecan’s financial strategy, process optimization, and operational excellence ...

Mesoblast’s Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved ...

From FY2026, focused restructuring, renewed R&D focus, and efficiency and digital initiatives will deliver near-term cost savings to enhance our path to profitability, including an expected minimum ...

L’avis de réunion a été publié au BALO (Bulletin des Annonces Légales Obligatoires) le lundi 3 novembre 2025 et contient l’ordre du jour, le projet de résolutions et les principales modalités de ...